CoChat

Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation

Open access

The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.

Abstract

Human BCL-2-associated death promoter (hBAD) is an apoptosis-regulatory protein mediating survival signals to carcinoma cells upon phosphorylation of Ser99, among other residues. Herein, we screened multiple small-molecule databases queried in a Laplacian-modified naive Bayesian-based cheminformatics platform and identified a Petasis reaction product as a site-specific inhibitor for hBAD phosphorylation. Based on apoptotic efficacy against mammary carcinoma cells, N -cyclopentyl-3-((4-(2,3-dichlorophenyl) piperazin-1-yl) (2-hydroxyphenyl) methyl) benzamide (NPB) was identified as a potential lead compound. In vitro biochemical analyses demonstrated that NPB inhibited the phosphorylation of hBAD specifically on Ser99. NPB was observed to exert this effect independently of AKT and other kinase activities despite the demonstration of AKT-mediated BAD-Ser99 phosphorylation. Using a structure-based bioinformatics platform, we observed that NPB exhibited predicted interactions with hBAD in silico and verified the same by direct binding kinetics. NPB reduced phosphorylation of BAD-Ser99 and enhanced caspase 3/7 activity with associated loss of cell viability in various human cancer cell lines derived from mammary, endometrial, ovarian, hepatocellular, colon, prostatic, and pancreatic carcinoma. Furthermore, by use of a xenograft model, it was observed that NPB, as a single agent, markedly diminished BAD phosphorylation in tumor tissue and significantly inhibited tumor growth. Simila…

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.1804897115

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 2

  1. 10.1021/ci049714 · DOI
  2. 10.1110/ps.9.12.2528 · doi:10.1110/ps.9.12.2528 · Paper page

Cited by

See all 60

Metadata

Authors
Pandey, V., Wang, B., Mohan, C. D., Raquib, A. R., Rangappa, S., Srinivasa, V., Fuchs, J. E., Girish, K. S., Zhu, T., Bender, A., Ma, L., Yin, Z., Basappa, Rangappa, K. S., & Lobie, P. E.
Affiliations
  • Tsinghua–Berkeley Shenzhen Institute (CN)
  • Jinan University (CN)
  • University of Mysore (IN)
  • National University of Singapore (SG)
  • Adichunchanagiri Institute for Molecular Medicine, BG Nagara, 571448 Karnataka, India;
  • Bangalore University (IN)
  • University of Cambridge (GB)
  • Tumkur University (IN)
  • University of Science and Technology of China (CN)
  • Laboratory of Chemical Biology, Department of Chemistry, Bangalore University, 560001 Bangalore, India;
Venue
Proceedings of the National Academy of Sciences
Published
2018-10-11
Volume
115
Issue
44
Pages
E10505-E10514
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2896536135
Cited by
59
References
75
Citations by year
2026: 3 · 2025: 7 · 2024: 5 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 1
FWCI
2.49
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • MyPrints@UOM (Mysore University Library) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Bad phosphorylation, small molecule inhibitors, NPB, caspase-3/7 activation, apoptosis, cancer cell lines, xenograft tumor growth, structure-based drug design, anticancer agents
MeSH terms
Antineoplastic Agents, Benzamides, Cell Survival, Humans, Phosphorylation, Piperazines, Serine, Databases, Factual, Drug Delivery Systems, Apoptosis, Surface Plasmon Resonance, RNA Interference, Cell Proliferation, bcl-Associated Death Protein, Small Molecule Libraries, Drug Discovery, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation. https://app.cochat.ai/papers/10.1073/pnas.1804897115
The paper
Pandey, V., Wang, B., Mohan, C. D., Raquib, A. R., Rangappa, S., Srinivasa, V., Fuchs, J. E., Girish, K. S., Zhu, T., Bender, A., Ma, L., Yin, Z., Basappa, Rangappa, K. S., & Lobie, P. E. (2018). Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1804897115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.